AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $362,617 | -14.5% | 5,189 | -12.1% | 0.00% | 0.0% |
| Q2 2023 | $424,170 | -0.4% | 5,902 | -14.5% | 0.00% | 0.0% |
| Q1 2023 | $425,802 | +8.4% | 6,904 | +35.5% | 0.00% | 0.0% |
| Q4 2022 | $392,785 | +44.4% | 5,096 | -16.7% | 0.00% | 0.0% |
| Q3 2022 | $272,000 | +38.1% | 6,116 | +19.4% | 0.00% | – |
| Q2 2022 | $197,000 | -16.9% | 5,121 | -6.1% | 0.00% | – |
| Q1 2022 | $237,000 | +9.2% | 5,453 | -4.8% | 0.00% | – |
| Q4 2021 | $217,000 | +11.3% | 5,730 | -2.9% | 0.00% | – |
| Q3 2021 | $195,000 | -30.1% | 5,901 | +42.3% | 0.00% | -100.0% |
| Q2 2021 | $279,000 | +47.6% | 4,147 | +24.6% | 0.00% | – |
| Q1 2021 | $189,000 | +33.1% | 3,328 | +90.9% | 0.00% | – |
| Q4 2020 | $142,000 | +6.8% | 1,743 | -6.7% | 0.00% | – |
| Q3 2020 | $133,000 | -39.3% | 1,869 | -30.0% | 0.00% | -100.0% |
| Q2 2020 | $219,000 | -21.8% | 2,669 | -43.9% | 0.00% | 0.0% |
| Q1 2020 | $280,000 | – | 4,759 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |